📰 Nasdaq Avtx News
Nasdaq Avtx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Avtx. Real-time updates on events, politics, business and more.
December 31, 2023
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 12,640,000 shares, a growth of 23.8% from the November 30th total of 10,210,000 shares. Based on an average trading volume of 51,393,300 shares, the short-interest ratio […]
August 1, 2023
Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) will be announcing its earnings results on Wednesday, August 2nd. Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) last released its earnings results on Thursday, May 4th. The company reported ($0.85) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.97) by $0.12. The firm had […]
August 1, 2023
Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) is scheduled to be releasing its earnings data on Wednesday, August 2nd. Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) last posted its earnings results on Thursday, May 4th. The company reported ($0.85) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.97) by $0.12. The business […]
July 30, 2023
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 887,000 shares, a growth of 41.2% from the June 30th total of 628,400 shares. Currently, 7.4% of the shares of the stock are […]
June 20, 2023
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. acquired 3,000 shares of the firm’s stock in a transaction that occurred on Friday, June 16th. The stock was purchased at an average cost of $3.90 per share, for a total transaction of $11,700.00. Following the completion of the purchase, the insider […]
May 30, 2023
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 43,800 shares, an increase of 17.1% from the April 30th total of 37,400 shares. Based on an average trading volume of 48,000 shares, the short-interest ratio is […]
May 28, 2023
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) was the target of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 43,800 shares, an increase of 17.1% from the April 30th total of 37,400 shares. Approximately 0.4% of the company’s shares are short sold. Based […]
May 25, 2023
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. bought 13,121 shares of the firm’s stock in a transaction on Thursday, May 18th. The stock was acquired at an average price of $3.29 per share, for a total transaction of $43,168.09. Following the completion of the purchase, the insider now directly […]
May 22, 2023
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. bought 7,000 shares of the business’s stock in a transaction that occurred on Monday, May 22nd. The stock was purchased at an average price of $3.34 per share, with a total value of $23,380.00. Following the completion of the purchase, the insider […]
May 22, 2023
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. acquired 13,121 shares of the business’s stock in a transaction that occurred on Thursday, May 18th. The stock was acquired at an average cost of $3.29 per share, with a total value of $43,168.09. Following the completion of the acquisition, the insider […]